Enhancing Oncology Clinical Trials Through The Use Of Digital Technologies
August 17th 2022Wed, Aug 17, 2022 2:00 PM EDT Recent advances in both oncology drug development and novel digital technologies provide a ripe opportunity to enhance the clinical trial process. Join Colin Weller and Musaddiq Khan from Medable as they discuss the key considerations around these innovations.
Developing GMP-Manufactured Cas9 Proteins for Therapeutic Applications
June 30th 2022Thursday, June 30, 2022 at 11am PST | 1pm CST | 2pm EST As CRISPR based gene editing progresses from research to therapeutic applications, there is a growing need for high quality GMP grade materials, including the Cas9 protein and supporting instruments, and to minimize off target events. This webinar will discuss the development process of a GMP-manufactured Cas9 protein along with causes of off target events and how to minimize risk with high fidelity Cas9 protein.
The Ever-Changing World of Extractables and Leachables, Part 4, A Free Virtual Conference
May 18th 2022Wednesday, May 18th, 2022 at 3pm BST | 10am EDT | 4pm CEST | 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.
Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use
April 26th 2022Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.
Plan Now or Fail Later: Why raw materials matter
April 13th 2022Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..
Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization
April 12th 2022Tuesday, April 12th 2022 at 10 am EDT | 7 am PDT | 3 pm GMT Freezing and thawing biotherapeutics requires experienced leadership to navigate material and instrument selection as well as quality, space, regulatory and other considerations in creating a new cold-chain ecosystem. This webinar discusses the design of processes in partnership with a uniquely resourced freeze/thaw technology center.
Oligonucleotide Purification and Characterization - Tips for Success
March 30th 2022Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.
Automation of MS Analytics for Characterization of Biotherapeutics
March 17th 2022March 17th 2022 at 10am EST | 9am CST | 3pm GMT | 4pm CET • Automating and Streamlining MS-Based Developability Assessment of Biotherapeutics• Automating MS-Based Biotherapeutic Characterization Workflows for Developability
Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries
March 16th 2022Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.
Managing Growth During Covid: A Supply Chain Perspective
March 1st 2022This webcast is now available on demand! The delicate dance between strategic initiatives of continuous improvement and maintaining daily operational discipline amid the significant challenges placed on global supply chains by COVID-19. This webcast will discuss the risk-based approach used to minimize procurement risk and optimize material readiness.
Laying the Foundation for Smart Manufacturing While Solving Today’s Tough Challenges On Demand
February 28th 2022Monday, February, 28, 2022 at 9am EST | 8am CST | 6am PST Realizing benefits from Smart Manufacturing technologies doesn’t have to be long-term prospect. Solve today’s manufacturing challenges while laying the foundation for tomorrow’s plant.
Mitigate Risk, Increase Speed & Reduce Complexity with Customized Single-Use Systems
February 22nd 2022Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.
Methodology Development for Complete Nucleoside and Nucleotide Monitoring within Cell Samples
February 8th 2022Tuesday, February 8th, 2022 at 9am EST | 3pm CET | 2pm GMT and 2pm EST | 11am PST | 7pm GMT Approaches and lessons learned on developing an HPLC methodology to cover a complex and broad range of polar analytes: the complete cellular pool of nucleosides and nucleotides plus our drug candidates and associated prodrugs. The utility of PEEK-lined columns and newer HILIC-Z column phases is highlighted in this anecdote of HPLC methodology development.
Quality by Design and Container Closure Integrity
February 8th 2022Wednesday, February 8th at 11am EST | 10am CST | 8am PST Industry shifts in container closure integrity (CCI) are driving the next generation of quality control solutions. Understanding the physics behind the technologies and their relation to your application will carve a path of successful CCI assurance.
Rapid Analysis of mRNA 5’ Capping and Poly-A Tailing with High-Resolution LC-MS
January 11th 2022Tuesday, January, 11th, 2022 at 9am EST | 3pm CET | 2pm GMT Tuesday, January, 11th, 2022 at 2pm EST | 11am PST | 7pm GMToin us in our expert discussion of Rapid Analysis of mRNA 5’ Capping and Poly-A Tailing with High-Resolution LC-MS. See how mRNA capping can be analyzed by LC-MS within 75 minutes!
Novel approach to automating Maxi-, Mega-, and Giga-plasmid DNA preparations
December 2nd 2021Broadcast 1 (APAC): Thursday December 2, 2021 at 10:00am CST | 11:00am JST Broadcast 2 (EMEA): Thursday December 2, 2021 at 2:00pm GMT | 1:00pm CET Broadcast 3 (Americas): Thursday December 2, 2021 at 2pm EST | 1pm CST | 11am PST Interested in automating your plasmid purification work? Learn how you can automate your Maxi, Mega and Giga preparations with consistent purity and transfection efficiency
Automating Routine Analysis of Therapeutic mAbs in High Volume Applications
December 1st 2021Wednesday, December 1st, 2021 at 11 am EST | 10 am CST | 8 am PST Learn how to accelerate therapeutic mAbs workflows by automating analysis of critical quality attributes (CQAs) such as Fc glycosylation, oxidation, C-terminal lysine clipping, and glycation.
Impact of Scalable Freeze/Thaw Cycling on Protein Stability & Structure
October 27th 2021**Wednesday, October 27, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST** Freezing and thawing at scale of API and BDS biologics is not routine and should be handled with the consideration given to any critical unit operation. This webinar highlights key protein related quality challenges associated with freeze methods. Optimization thorough model freeze/thaw studies are presented.
Moving SWATH LC–MS Host Cell Protein Analysis into a GMP Environment?
October 6th 2021Wednesday, October 6, 2021 at 12pm EDT | 9am PDT | 5pm BST | 6pm CEST In this webinar, you will learn about the possibility of GMP method transfer for HCP assays leveraging a robust and automated workflow based on combining data-dependent and data-independent mass spectrometry. A study of data from multiple projects over three years demonstrated the robustness and reproducibility of the method.
The Ever-Changing World of Extractables and Leachables: Lessons learned and future challenges
October 4th 2021October 4, 2021 at 3pm BST | 10am EST | 4pm CEST Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.
Increasing Upstream Bioprocessing Efficiency through Process Analytical Technology
September 29th 2021Wednesday, September 29, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Learn about strategies for inline process analytics aimed at automated feed control in an upstream bioprocess. Using the example of a Raman analyzer, a glucose analyzer, and an exhaust analyzer experts demonstrate how to achieve seamless sensor integration with the bioprocess control software.
Personalized Medicines: Advances in Genetics and Bioinformatics
September 23rd 2021Thursday, September 23, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Find out about the challenges of manufacturing personalized medicines and the lessons being learned from the pandemic with a vaccine developer and process equipment manufacturers.